Zdrowie i gospodarka · 09/03/2016

FDA Releases Guidance on Investigating Adverse Reactions from Human Cells, Tissues, and Products

The FDA has published a new guidance document outlining recommendations for investigating and reporting adverse reactions related to human cells, tissues, and cellular and tissue-based products, which are not subject to premarket submissions and are regulated under Section 361 of the Public Health Service Act.